🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationFDA warning letters to compounding pharmacies — November 2025 Page 6

FDA warning letters to compounding pharmacies — November 2025

gary_naperville Sun, Mar 15, 2026 at 7:46 PM 36 replies 1,552 viewsPage 6 of 8
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Mar 16, 2026 at 4:16 AM#26

Congrats gary_naperville!! Keep going — you're doing incredible. 🎉

29 15PharmHunterJen, TomTeleRx, DoseLogDan and 26 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Mar 16, 2026 at 4:33 AM#27

Slightly tangential to FDA warning letters to but Admin reminded me — has the insurance landscape changed recently?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

7 24roxy_nash, tony_orlando, Dr.NephBHM_UK and 4 others
Reply Quote Save Share Report
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Mar 16, 2026 at 4:50 AM#28

100%. My provider said the same thing about FDA warning letters.

Last edited: Mar 16, 2026 at 5:50 AM
41 20FranDenver, Dr.BariatricHTX, LindaRN_retired and 38 others
Reply Quote Save Share Report
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Mar 16, 2026 at 5:07 AM#29

Reading this thread on FDA warning letters to hits close to home. Dad of 2 checking in — I started at 289 lbs and felt like I would tried everything.

15 months on tirz and I am a different person. Not just the 64 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about FDA warning letters — take the leap. It was the best health decision I have ever made. ❤️

25 15TomFromTexas, mike.trainer_LA, sarah_nash92 and 22 others
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Mar 16, 2026 at 5:24 AM#30

As a healthcare provider, I want to add some clinical context to this discussion on FDA warning letters to compounding.

Building on what BiostatsBrad said — the evidence base here is well-established. The key publications to reference are from the STEP program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
22 13ChrisMacros, KetoKyle, CanadaChris and 19 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register